Pfizer Invites Shareholders to Attend Virtual-Only 2022 Annual Meeting of Shareholders on April 28 Life Science Investing News
Allergan, an AbbVie Company, to Present New Data from its Eye Care Portfolio at the 2022 American Society of Cataract and Refractive Surgery Annual Meeting Pharmaceutical Investing
Kite Receives U.S. FDA Approval of New State-of-the-Art CAR T-Cell Therapy Manufacturing Facility in Maryland Pharmaceutical Investing
Aurinia Announces Year-Two Commitment to Patient Navigation Grant Program to Address Barriers for Individuals Living with Lupus and Lupus Nephritis Pharmaceutical Investing
Aurinia Pharmaceuticals Inc. Class Action: Levi & Korsinsky Reminds Aurinia Pharmaceuticals Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 14, 2022 - AUPH Pharmaceutical Investing
Shareholder Alert: Robbins LLP Informs Investors of Class Action Against Aurinia Pharmaceuticals Inc. Pharmaceutical Investing
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of TASK, MYPS and AUPH Pharmaceutical Investing
DEADLINE ALERT for GWGH, ABBV, MYPS, and SDIG: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders Pharmaceutical Investing
LAWSUITS FILED AGAINST AFRM, AKBA and AUPH - Jakubowitz Law Pursues Shareholders Claims Pharmaceutical Investing
EQUITY ALERT: Rosen Law Firm Encourages Aurinia Pharmaceuticals Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - AUPH Pharmaceutical Investing
